These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 793914)

  • 1. Results of potency tests of a vaccine against Cl. botulinum type C by different methods.
    Pranter W
    Dev Biol Stand; 1976; 32():185-91. PubMed ID: 793914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Method of quantitative determination of vaccine activity against botulism of the mink].
    Kirillov LV
    Dev Biol Stand; 1976; 32():203-9. PubMed ID: 793916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitoxin responses to Clostridium botulinum vaccines types C and D in guinea pigs.
    Mathews AG
    Dev Biol Stand; 1976; 32():193-201. PubMed ID: 793915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Sun ZW; Wang S; Yu WY
    Vaccine; 2007 Dec; 25(52):8843-50. PubMed ID: 18022294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate.
    Yu YZ; Li N; Zhu HQ; Wang RL; Du Y; Wang S; Yu WY; Sun ZW
    Vaccine; 2009 May; 27(21):2816-22. PubMed ID: 19428892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunization of broiler chickens against type C botulism.
    Dohms JE; Allen PH; Cloud SS
    Avian Dis; 1982; 26(2):340-5. PubMed ID: 7049149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Clostridium botulinum type C antitoxin titers in mink and guinea pigs to protection against type C intoxication in mink.
    Kolbe DR; Coe Clough NE
    Anaerobe; 2008 Apr; 14(2):128-30. PubMed ID: 18032073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency testing of Clostridium septicum bacterins in sheep and laboratory animals.
    Cardella MA; Kolbe DR
    Dev Biol Stand; 1976; 32():115-22. PubMed ID: 1001825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
    Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3.
    Webb RP; Smith TJ; Wright P; Brown J; Smith LA
    Vaccine; 2009 Jul; 27(33):4490-7. PubMed ID: 19450643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. I. Response to botulinum toxoid.
    Galazka A; Rymkiewicz D; Aleksandrowicz J
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):631-9. PubMed ID: 793566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a type C botulism vaccine in green-winged teal.
    Rocke TE; Samuel MD; Swift PK; Yarris GS
    J Wildl Dis; 2000 Jul; 36(3):489-93. PubMed ID: 10941734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the effect of the diluent used for diluting challenge toxin in the Clostridium botulinum potency test.
    Sawtell JA; Ream AJ
    Biologicals; 1995 Sep; 23(3):249-51. PubMed ID: 8527126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward development of an inhalation vaccine against botulinum toxin.
    Park JB; Simpson LL
    Expert Rev Vaccines; 2004 Aug; 3(4):477-87. PubMed ID: 15270652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.